Chronic Pain Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 20+ Companies Working in the Domain
Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...
HOOKIPA Pharma Inc.: HOOKIPA Pharma Announces Enrollment Completion of Phase 1b Clinical Trial Evaluating HB-500 for the Treatment of HIV
HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of a curative regimen for human immunodeficiency virus (HI ...
Healio10h
Decentralized clinical trials: FDA guidance and the ‘new modus operandi’
The COVID-19 pandemic forced investigators conducting clinical trials to use decentralized elements, such as telehealth, to ...
Targeted Oncology1h
Exploring Zoldonrasib, Pan-RAS Inhibitors, and Future KRAS Therapies
Alexander I. Spira, MD, PhD, FACP, discusses the next steps in the clinical development of zoldonrasib for patients with KRAS ...
GlobalData on MSN8h
Shionogi’s RSV antiviral reduces viral load in Phase II human challenge trial
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...
appliedclinicaltrialsonline5h
Merck Stops HYPERION Trial for Winrevair in PAH Following Positive ZENITH Trial Results
The Phase III HYPERION trial was stopped early after strong positive interim results from the ZENITH trial demonstrated the efficacy of Winrevair (sotatercept-csrk) in treating pulmonary arterial ...
How UCLA Health’s Legacy of Theranostics Innovation Transforms Cancer Care
UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...
MindMed launches phase 3 trial for anxiety treatment
The MM120 ODT Phase 3 clinical development program also includes the Voyage study for GAD and the Emerge study for major depressive disorder (MDD). The U.S. Food and Drug Administration has granted ...
Psychology Today4h
5 Ways to Rescript the 'Third Act' of Your Relationship
The “terror management theory” suggests that awareness of life’s finiteness shapes our actions and decisions. The third act is a chance to craft a love story that honors the past and evolves to meet ...
DiaMedica Therapeutics: Interesting Work In Treating Ischemic Stroke
DiaMedica's DM199 shows promise for Acute Ischemic Stroke, but caution is advised due to low market cap and trial outcome uncertainties. See more on DMAC here.
The American Journal of Managed Care4h
Oncology R&D Will Follow Divergent Paths, Experts Say at JPM Event
A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
clinicaltrialsarena21h
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo
The trial combines tislelizumab and Anktiva for treating advanced or metastatic non-small cell lung cancer patients. Credit: NMK-Studio/Shutterstock. ImmunityBio has entered a supply agreement and ...